Organon: Valuation Discount Offset By Structural Headwinds

Organon & Co.'s (NYSE: OGN ) securities now look very cheap: the forward P/E is about 2.4x against the sector average of 17x, and after the separation from Merck, the price went below $10. But cheap does not mean that thereHi there! I’m Narek, and I’ve been in the investment world for over six years. I started out as an equity analyst at European banks, digging into reports and learning how to spot value in the markets. I’ve worked across sectors — from telecom to industry — and found that behind every fina ...